| Insurance Industry | Financials Sector | Mr. Wade Menpes-Smith CEO | XMUN Exchange | - ISIN |
| Germany Country | 3 Employees | 28 Mar 2025 Last Dividend | - Last Split | - IPO Date |
Aladdin Healthcare Technologies SE is a pioneering company focusing on the innovative use of blockchain technology to enhance healthcare. By leveraging blockchain, the company ensures secure and efficient storage and management of health-related information. With its subsidiary, Aladdin Healthcare Technologies Ltd, it is at the forefront of harnessing Artificial Intelligence (AI) for the discovery of new drugs and the improvement of healthcare outcomes. The company, founded in 2014 and based in Berlin, Germany, is making significant strides in addressing the challenges posed by age-related diseases, such as Alzheimer's and Parkinson's, as well as emerging threats like SARS-CoV-2.
This platform utilizes AI to speed up the process of discovering small molecule drug compounds that can potentially treat multiple age-related diseases, including Alzheimer's, Parkinson's, and SARS-CoV-2. By applying advanced algorithms and machine learning techniques, this platform aims to streamline the drug discovery process, making it faster and more cost-effective.
PharmaKG is a biomedical knowledge graph that integrates various sources of data to facilitate a deeper understanding of the connections between genes, diseases, drugs, and biological pathways. This comprehensive database aids researchers in uncovering new insights and improving the accuracy of biomedical research outcomes.
This platform leverages AI to provide enhanced diagnostic tools and risk assessment models for healthcare providers. By analyzing vast amounts of health data, it offers more accurate diagnoses and forecasts, contributing to more personalized and effective treatment plans for patients.